HKPD NASDAQ
Cellyan Biotechnology Co., Ltd
1W: -2.1%
1M: -28.0%
3M: -76.4%
YTD: -86.4%
1Y: -92.4%
$0.11
-0.00 (-2.06%)
Weekly Expected Move ±10.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$752K
-232.0% ▼
Capital Expenditures
$35K
+77.1% ▲
3Y CAGR: -33.0%
Free Cash Flow
-$787K
-290.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$527K
-532.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | $998K | $1M | -$27K | -$1M |
| Depreciation & Amort. | $715K | $926K | $1M | $687K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | $14K | -$3M | -$520K | $726K |
| Other Non-Cash Items | $0 | -$708 | $43K | -$1M |
| Operating Cash Flow | $2M | -$394K | $569K | -$752K |
| — Investing Activities — | ||||
| Capital Expenditures | -$115K | -$53K | -$70K | -$35K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$2M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | -$17K | $12K | -$85K | $893K |
| Investing Cash Flow | -$132K | -$41K | -$2M | $857K |
| — Financing Activities — | ||||
| Net Debt Issuance | -$1M | $373K | -$927K | -$630K |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$345K | -$1M | $0 |
| Financing Cash Flow | -$1M | $537K | $2M | -$630K |
| Net Change in Cash | $440K | $103K | $122K | -$527K |
| Cash End of Period | $525K | $627K | $749K | $222K |
| Free Cash Flow | $2M | -$482K | $414K | -$787K |